IP Library Granted Patent US 10,307,607
Granted Patent B2
US 10,307,607 · App. 15/019,702 · Granted Jun 4, 2019

Focused magnetic stimulation for modulation of nerve circuits

Inventors: Bernard D. Casse (Saratoga, CA); Victor Liu (Mountain View, CA)
Assignee: Palo Alto Research Center Incorporated
A61N2/006A61N2/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,307,607
App. No.
15/019,702
Granted
Jun 4, 2019
Kind
B2
Abstract

A neuromodulation device includes electrically conductive coils arranged in an array and circuitry coupled to energize the coils in the array using current pulses that generate an electromagnetic field. The circuitry is configured to control one or more parameters of the current pulses, including at least amplitude and phase of the current pulses, such that the electromagnetic field undergoes constructive and destructive interference that focuses and/or steers a magnetic flux density within a region of interest of a patient.

Claims (31)

1. A neuromodulation device comprising:

electrically conductive coils arranged in an array; and

circuitry coupled to energize the coils in the array using current pulses that generate an electromagnetic field, the circuitry configured to control one or more parameters of the current pulses, including at least amplitude and phase of the current pulses, such that the electromagnetic field undergoes constructive and destructive interference that focuses and/or steers a magnetic flux density within a region of interest of a patient and produces an electric field gradient and strength sufficient to activate one or more nerves within the region of interest while not activating nerves between the activated nerves and the electrically conductive coils.

2. The neuromodulation device of claim 1 , wherein the one or more current pulse parameters further include one or more of duty cycle and frequency.

3. The neuromodulation device of claim 1 , wherein the electric field has an electric field distribution spot size of at least 400 μm.

4. The neuromodulation device of claim 1 , wherein the electric field strength Ex=dV/dx in the region of interest is greater than about 100 V/m.

5. The neuromodulation device of claim 1 , wherein the current pulses have a maximum amplitude less than about 500 mA.

6. The neuromodulation device of claim 1 , wherein each of the coils comprises a plurality of stressed elastic members.

7. The neuromodulation device of claim 6 , wherein the plurality of stressed elastic members comprises:

a first stressed elastic member comprising a first anchor portion and a first free portion; and

a second stressed elastic member comprising a second anchor portion and a second free portion, wherein a stress profile in the first elastic member biases the first free portion away from a substrate and a stress profile in the second elastic member biases the second free portion away from the substrate and wherein the first free portion and the second free portion are connected together forming a loop winding.

8. The neuromodulation device of claim 1 , wherein the region of interest is located at a specified depth within the patient and an electric field produced by the neuromodulation device in a region between the region of interest and the neuromodulation device is less than the electric field in the region of interest.

9. The neuromodulation device of claim 1 , further comprising a flexible substrate, wherein the array of coils are disposed on the flexible substrate.

10. The neuromodulation device of claim 1 , wherein the neuromodulation device is an implantable nerve cuff or a dermal patch.

11. The neuromodulation device of claim 1 , further comprising energy harvesting circuitry configured to harvest power from a radio frequency (RF) signal generated by an external device and to use the harvested power to provide the current pulses.

12. The neuromodulation device of claim 1 , further comprising communications circuitry configured to wirelessly transfer communication signals between the neuromodulation device and an external device.

13. The neuromodulation device of claim 12 , wherein the communication signals include feedback information and the circuitry uses the feedback information to control the current pulse parameters.

14. The neuromodulation device of claim 13 , wherein the feedback information is based on biological signals sensed from the patient.

15. The neuromodulation device of claim 1 , wherein the circuitry includes a memory that stores one or more tables of current pulse parameter values for each coil in the array, each table corresponding to a particular profile of biological signals of the patient.

16. The neuromodulation device of claim 15 , wherein the current pulse parameter values are dynamically changeable in response to a change in the biological signals.

17. A neuromodulation system comprising:

a neuromodulation device comprising:

electrically conductive coils arranged in an array; and

circuitry coupled to energize the coils in the array with current pulses that generate an electromagnetic field, the circuitry configured to control one or more parameters of the current pulses, including at least amplitude and phase of the current pulses, such that the electromagnetic field undergoes constructive and destructive interference that focuses and/or steers a magnetic flux density within a region of interest of a patient and produces an electric field gradient and strength sufficient to activate one or more nerves within the region of interest while not activating nerves between the activated nerves and the electrically conductive coils; and

communications circuitry configured to wirelessly transfer communication signals between the neuromodulation device and an external device; and

a patient information device communicatively coupled to the neuromodulation device, the patient information device configured to monitor one or more biological signals of the patient and to transfer information about the biological signals to the neuromodulation device via the communication signals.

18. The neuromodulation system of claim 17 , wherein the region of interest is located at a specified depth within the patient and an electric field produced by the neuromodulation device in a region between the region of interest and the neuromodulation device is less than the electric field in the region of interest.

19. A neuromodulation method comprising:

energizing coils in an array of coils using current pulses, the current pulses generating an electromagnetic field that provides a magnetic flux density at a region of interest of a patient; and

controlling one or more parameters of the current pulses, including at least amplitude and phase, such that the electromagnetic field undergoes constructive and destructive interference that focuses and/or steers the magnetic flux density to the region of interest and produces an electric field gradient and strength sufficient to activate one or more nerves within the region of interest while not activating nerves between the activated nerves and the energized coils.

20. The method of claim 19 , wherein controlling the parameters comprises dynamically changing the parameters based on biological signals sensed from the patient.

Assignments (10)
SECOND LIEN NOTES PATENT SECURITY AGREEMENT Recorded Jul 2, 2025
From: XEROX CORPORATION
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 071785/0550 →
FIRST LIEN NOTES PATENT SECURITY AGREEMENT Recorded Apr 11, 2025
From: XEROX CORPORATION
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 070824/0001 →
SECURITY INTEREST Recorded Feb 13, 2024
From: XEROX CORPORATION
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 066741/0001 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT RF 064760/0389 Recorded Feb 13, 2024
From: CITIBANK, N.A., AS COLLATERAL AGENT
To: XEROX CORPORATION
Reel/Frame 068261/0001 →
SECURITY INTEREST Recorded Nov 20, 2023
From: XEROX CORPORATION
To: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 065628/0019 →
CORRECTIVE ASSIGNMENT TO CORRECT THE REMOVAL OF US PATENTS 9356603, 10026651, 10626048 AND INCLUSION OF US PATENT 7167871 PREVIOUSLY RECORDED ON REEL 064038 FRAME 0001. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 28, 2023
From: PALO ALTO RESEARCH CENTER INCORPORATED
To: XEROX CORPORATION
Reel/Frame 064161/0001 →
SECURITY INTEREST Recorded Jun 22, 2023
From: XEROX CORPORATION
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 064760/0389 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2023
From: PALO ALTO RESEARCH CENTER INCORPORATED
To: XEROX CORPORATION
Reel/Frame 064038/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE TO REMOVE THE INCORRECT SERIAL NO. 15/019,072 AND ADD CORRECT SERIAL NO. 15/019,702 PREVIOUSLY RECORDED ON REEL 037695 FRAME 0138. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF ASSIGNORS' INTEREST. Recorded Feb 25, 2016
From: CASSE, BERNARD D.; LIU, VICTOR
To: PALO ALTO RESEARCH CENTER INCORPORATED
Reel/Frame 038006/0433 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2016
From: CASSE, BERNARD D.; LIU, VICTOR
To: PALO ALTO RESEARCH CENTER INCORPORATED
Reel/Frame 037695/0138 →
Continuity (1)
Related Publication 20170225004A1 · Aug 10, 2017